Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:51:52.066Z.
Calculation as of: 2026-10-06T15:51:52.066Z.
Quote observation: 2026-10-06T15:50:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b6dd554127bde3e2857ddd2c1d40451f36e78030673a0e1a1dc90bdbe20c6bc6
EARNINGS YIELD
N/A
Market Cap
$3.56B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.43B
Earnings Yield
11.07%
TTM Avg
8.17%
3Y Avg
6.43%
5Y Avg
6.43%
Market Cap
$3.14B
Earnings Yield
N/A
TTM Avg
0.44%
3Y Avg
0.44%
5Y Avg
0.44%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iRhythm Technologies, Inc. (IRTC) | $3.53B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.55B | N/A | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.55B | N/A | N/A | N/A | N/A |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.56B | N/A | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.45B | 3.11% | 5.71% | 6.07% | 6.07% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.43B | 11.07% | 8.17% | 6.43% | 6.43% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.42B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.38B | N/A | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.14B | N/A | 0.44% | 0.44% | 0.44% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | 0.84% | 0.82% | 0.82% | 0.82% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
